Contract N6854622F6044
Microgenics Corporation · Department Of Defense · April 30, 2022
Microgenics Corporation was awarded a federal contract by Department Of Defense (Department Of The Navy) on April 30, 2022 for $998 of work in in-vitro diagnostic substance manufacturing. Performance is in Fremont, CA. This is a task or delivery order issued under parent IDIQ N6264518D5061. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 6, 2022.
Contract details
- PIID
- N6854622F6044
- Parent IDIQ
- N6264518D5061
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Competed Under Sap
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
- Place of performance
- Fremont, CA
- First action
- April 30, 2022
- Latest action
- September 6, 2022
Description
HYDROCODONE & HYDROMORPHONE REAGENT KITS
Modification timeline
-
September 6, 2022Mod P00001$0
-
April 30, 2022Base award$998
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Diasorin Inc | Department Of Defense | December 31, 2025 | $518.8K |
| Bloodworks | Department Of Defense | December 31, 2025 | $160.2K |
| Sl Meditech Co. | Department Of Defense | December 31, 2025 | $151.6K |
| Alba Bioscience, Inc. | Department Of Defense | December 31, 2025 | $163.2K |
| Werfen USA Llc | Department Of Defense | December 31, 2025 | $18.1K |
| Immucor Inc | Department Of Defense | December 31, 2025 | $154.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Abbott Rapid Dx North America Llc | 651 | $3.51B |
| 2 | Ihealth Labs Inc. | 4 | $2.13B |
| 3 | Roche Diagnostics Corporation | 5,604 | $959.60M |
| 4 | Siemens Healthcare Diagnostics Inc. | 818 | $641.45M |
| 5 | Cepheid | 3,693 | $639.45M |
| 6 | Remel Inc. | 4,525 | $464.47M |
| 7 | Access Bio, Inc. | 5 | $340.72M |
| 8 | Ortho-Clinical Diagnostics, Inc | 1,964 | $227.77M |
| 9 | Quidel Corp | 96 | $194.78M |
| 10 | Ortho-Clinical Diagnostics Inc | 2,494 | $183.46M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract N6854622F6044?
Contract N6854622F6044 is a federal contract awarded to Microgenics Corporation by Department Of Defense on April 30, 2022 for $998 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 1 time since the base award.
Who won contract N6854622F6044?
Microgenics Corporation won contract N6854622F6044 from Department Of Defense.
How much is contract N6854622F6044 worth?
Contract N6854622F6044 has obligated $998 to date.